Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MARKSANS PHARMA.   TEVA PHARMA
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
TEVA PHARMA
Dec-13
MARKSANS PHARMA./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs743,481-   
Low Rs393,024-   
Sales per share (Unadj.) Rs40.91,997.6-  
Earnings per share (Unadj.) Rs5.9124.8-  
Cash flow per share (Unadj.) Rs7.0286.3-  
Dividends per share (Unadj.) Rs0.50109.24-  
Avg Dividend yield %0.93.4 26.3%  
Book value per share (Unadj.) Rs38.52,219.0-  
Shares outstanding (eoy) m453.16848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.6 85.0%   
Avg P/E ratio x9.726.1 37.1%  
P/CF ratio (eoy) x8.111.4 71.1%  
Price / Book Value ratio x1.51.5 100.2%  
Dividend payout %8.587.5 9.8%   
Avg Mkt Cap Rs m25,6312,757,874 0.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,3940-   
Avg. sales/employee Rs Th037,690.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,354.5-  
INCOME DATA
Net Sales Rs m18,5211,693,984 1.1%  
Other income Rs m5930-   
Total revenues Rs m19,1151,693,984 1.1%   
Gross profit Rs m3,393463,899 0.7%  
Depreciation Rs m519136,926 0.4%   
Interest Rs m9133,273 0.3%   
Profit before tax Rs m3,377293,700 1.1%   
Minority Interest Rs m01,334 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,798 -0.0%   
Tax Rs m723-3,586 -20.2%   
Profit after tax Rs m2,653105,822 2.5%  
Gross profit margin %18.327.4 66.9%  
Effective tax rate %21.4-1.2 -1,754.6%   
Net profit margin %14.36.2 229.3%  
BALANCE SHEET DATA
Current assets Rs m16,9971,144,111 1.5%   
Current liabilities Rs m3,654997,761 0.4%   
Net working cap to sales %72.08.6 833.9%  
Current ratio x4.71.1 405.7%  
Inventory Days Days691 6.3%  
Debtors Days Days8296 85.6%  
Net fixed assets Rs m5,246553,293 0.9%   
Share capital Rs m4534,170 10.9%   
"Free" reserves Rs m16,9980-   
Net worth Rs m17,4521,881,695 0.9%   
Long term debt Rs m0866,172 0.0%   
Total assets Rs m22,2423,871,297 0.6%  
Interest coverage x38.09.8 386.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.4 190.3%   
Return on assets %12.33.6 343.4%  
Return on equity %15.25.6 270.3%  
Return on capital %19.94.9 402.9%  
Exports to sales %00-   
Imports to sales %7.30-   
Net fx Rs m5,1430-   
CASH FLOW
From Operations Rs m2,374269,933 0.9%  
From Investments Rs m-2,592-95,648 2.7%  
From Financial Activity Rs m1,978-323,803 -0.6%  
Net Cashflow Rs m1,760-149,518 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare MARKSANS PHARMA. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare MARKSANS PHARMA. With: BLISS GVS PHARMA  ZENITH DRUGS LTD.  SMS LIFESCIENCES INDIA  AMRUTANJAN HEALTHCARE  DIVIS LABORATORIES  



Today's Market

Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.